Acute myeloid leukemia patients with NUP98 :: NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT
Annals of Hematology（2022）
关键词
flt3 inhibitors,leukemia,venetoclax
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要